Age, Biography and Wiki
Rory Collins (Rory Edwards Collins) was born on 3 January, 1955 in Hong Kong. Discover Rory Collins's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 69 years old?
Popular As |
Rory Edwards Collins |
Occupation |
N/A |
Age |
69 years old |
Zodiac Sign |
Capricorn |
Born |
3 January, 1955 |
Birthday |
3 January |
Birthplace |
Hong Kong |
Nationality |
Hong Kong |
We recommend you to check the complete list of Famous People born on 3 January.
He is a member of famous with the age 69 years old group.
Rory Collins Height, Weight & Measurements
At 69 years old, Rory Collins height not available right now. We will update Rory Collins's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
Physical Status |
Height |
Not Available |
Weight |
Not Available |
Body Measurements |
Not Available |
Eye Color |
Not Available |
Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
Family |
Parents |
Not Available |
Wife |
Not Available |
Sibling |
Not Available |
Children |
Not Available |
Rory Collins Net Worth
His net worth has been growing significantly in 2022-2023. So, how much is Rory Collins worth at the age of 69 years old? Rory Collins’s income source is mostly from being a successful . He is from Hong Kong. We have estimated
Rory Collins's net worth
, money, salary, income, and assets.
Net Worth in 2023 |
$1 Million - $5 Million |
Salary in 2023 |
Under Review |
Net Worth in 2022 |
Pending |
Salary in 2022 |
Under Review |
House |
Not Available |
Cars |
Not Available |
Source of Income |
|
Rory Collins Social Network
Timeline
He has created and led large studies that transformed statins from esoteric drugs for familial hypercholesterolaemia into widely used generics that reportedly prevent millions of heart attacks and ischaemic strokes annually. His large placebo-controlled trials and worldwide Cholesterol Treatment Trialists’ meta-analyses confirmed heart attack reduction, discovered stroke reduction, and demonstrated safety and efficacy in many different types of patient. His research has been funded by the Medical Research Council (MRC).
Collins was knighted in the 2011 New Year Honours for services to science. He was elected as a Fellow of the Academy of Medical Sciences in 2004 and a Fellow of the Royal Society (FRS) in 2015.
Since 1985, Collins has been co-director with Sir Richard Peto of the University of Oxford's Clinical Trial Services and Epidemiological Studies units. In 1996, he was appointed Professor of Medicine and Epidemiology at Oxford, supported by the British Heart Foundation. Since September 2005, he has also been acting as the Principal Investigator and Chief Executive of the UK Biobank,, a prospective study of 500,000 British people, aged 40–69 at recruitment.
Collins was educated at Dulwich College and studied Medicine at St Thomas's Hospital Medical School, part of the University of London (1974-1980), and Statistics at George Washington University from 1976 to 1977 and the University of Oxford from 1982 to 1983.
Sir Rory Edwards Collins FMedSci FRS (born 3 January 1955) is a British physician who is Professor of Medicine and Epidemiology at the Clinical Trial Service Unit within the University of Oxford, the head of the Nuffield Department of Population Health and a Fellow of Green Templeton College, Oxford. His work has been in the establishment of large-scale epidemiological studies of the causes, prevention and treatment of heart attacks, other vascular disease, and cancer, while also being closely involved in developing approaches to the combination of results from related studies ("meta-analyses").